Clinical data 67, 300 persons - Genetic data 47,797
Cohort |
GSA |
OE |
WT |
HC_total |
1183 |
5881 |
413 |
MS_women |
2559 |
4777 |
314 |
MS men |
1031 |
1808 |
125 |
HC_women |
839 |
4426 |
319 |
HC men |
344 |
1455 |
94 |
MS_total |
4944 |
12527 |
854 |
Sex MS |
3590 |
6585 |
439 |
Age at onset |
3262 |
6370 |
440 |
Course of disease |
3382 |
6337 |
423 |
EDSS at diagnosis |
1520 |
5683 |
411 |
EDSS at date of last
examination |
1519 |
5683 |
411 |
3 or more EDSS measures |
1553 |
1824 |
136 |
Cerebrospinal fluid
IgG-index |
859 |
2585 |
274 |
Oligoclonal band status
in CSF |
934 |
2888 |
295 |
Plasma NFL |
1665 |
2199 |
348 |
Any treatment data |
2862 |
2364 |
165 |
Any MRI data |
324 |
472 |
122 |
N=510
Prospective cohort study protocol
Site |
M0 |
M6 |
M12 |
M24 |
M36 |
M48 |
M60 |
Spain |
26 |
0 |
22 |
20 |
19 |
9 |
1 |
Italy 1 |
50 |
34 |
35 |
47 |
19 |
5 |
1 |
Italy 2 |
168 |
55 |
155 |
147 |
42 |
0 |
0 |
Italy 3 |
3 |
3 |
3 |
0 |
0 |
0 |
0 |
Germany |
89 |
82 |
80 |
78 |
65 |
40 |
19 |
Belgium |
32 |
0 |
31 |
27 |
24 |
0 |
0 |
Sweden |
70 |
0 |
69 |
65 |
59 |
37 |
3 |
Norway |
29 |
28 |
28 |
28 |
27 |
15 |
4 |
Denmark |
50 |
50 |
49 |
46 |
39 |
18 |
4 |
Variable |
M0 |
M6 |
M12 |
M24 |
M36 |
M48 |
M60 |
bmi |
510 |
252 |
472 |
458 |
291 |
123 |
32 |
disease_course |
510 |
252 |
472 |
458 |
291 |
123 |
32 |
EDSS |
511 |
250 |
471 |
457 |
292 |
124 |
31 |
New_relapse_at_timepoint |
517 |
252 |
472 |
458 |
294 |
124 |
32 |
mri_cervical_date |
503 |
140 |
281 |
424 |
180 |
62 |
12 |
mri_cranial_date |
504 |
219 |
359 |
428 |
247 |
105 |
30 |
mri_thoracix_date |
502 |
139 |
280 |
422 |
176 |
62 |
12 |
BDI_score |
510 |
193 |
469 |
433 |
290 |
122 |
32 |
Peg_test_dominant_hand_trial1 |
506 |
196 |
467 |
430 |
287 |
120 |
31 |
Peg_test_dominant_hand_trial2 |
504 |
195 |
467 |
428 |
287 |
120 |
31 |
Peg_test_non-dominant_hand_trial1 |
507 |
196 |
466 |
430 |
287 |
120 |
31 |
Peg_test_non-dominant_hand_trial2 |
506 |
196 |
467 |
427 |
287 |
120 |
31 |
25_Foot_walk_test1 |
506 |
196 |
468 |
434 |
288 |
120 |
31 |
25_Foot_walk_test2 |
505 |
196 |
468 |
434 |
288 |
120 |
31 |
25_Foot_walk_test_device |
511 |
247 |
472 |
458 |
293 |
122 |
31 |
PASAT_3_test |
269 |
164 |
229 |
208 |
125 |
47 |
20 |
FSMC_cognitive_score |
510 |
191 |
468 |
433 |
292 |
123 |
32 |
FSMC_motor_score |
510 |
191 |
468 |
433 |
292 |
123 |
32 |
FSMC_total_score |
510 |
191 |
468 |
433 |
292 |
123 |
32 |
FSMC_cognitive_fatigue_level |
510 |
191 |
468 |
433 |
292 |
123 |
32 |
FSMC_motor_fatigue_level |
510 |
191 |
468 |
433 |
292 |
123 |
32 |
FSMC_total_fatigue_level |
510 |
191 |
468 |
433 |
292 |
123 |
32 |
SF36_physical_functioning |
507 |
193 |
469 |
434 |
291 |
122 |
32 |
SF36_role_lim_physical |
507 |
193 |
469 |
434 |
291 |
122 |
32 |
SF36_role_lim_emotion |
507 |
193 |
469 |
434 |
291 |
122 |
32 |
SF36_energy |
507 |
193 |
469 |
434 |
291 |
122 |
32 |
SF36_emotional_wellbeing |
507 |
193 |
469 |
434 |
291 |
122 |
32 |
SF36_social_functioning |
507 |
193 |
469 |
434 |
291 |
122 |
32 |
SF36_pain |
507 |
193 |
469 |
434 |
291 |
122 |
32 |
SF36_general_health |
507 |
193 |
469 |
434 |
291 |
122 |
32 |
SDMT_oral_score |
509 |
197 |
468 |
429 |
285 |
120 |
31 |
Immunophenotyping |
145 |
0 |
227 |
0 |
0 |
0 |
0 |
Genotyping |
463 |
0 |
0 |
0 |
0 |
0 |
0 |
TREC |
454 |
0 |
454 |
0 |
0 |
0 |
0 |
KREC |
472 |
0 |
471 |
0 |
0 |
0 |
0 |
Are you interested in collaborating with us or accessing our data? We'd love to hear from you!
To proceed, please contact us with the following details:
We have a streamlined process to facilitate collaborations and data access for industry and academic research purposes. Our team will review your request and guide you through the necessary steps to ensure a smooth and productive partnership.
Prof. Ingrid Skelton Kockum – ingrid.kockum@ki.se
Dr. Alexandra Gyllenberg – alexandra.gyllenberg@ki.se
MultipleMS is funded by the European Union under the Horizon 2020 programme, grant agreement 733161. The contents of this website are the sole responsibility of the MultipleMS project and do not necessarily reflect the views of the European Union.
Horizon 2020
European Union Funding
for Research & Innovation